Tag: Silk Road Medical

popular

Vascular News’ top 10 most popular stories of September 2022

September's top 10 highlights a randomised trial that aims to examine early endovascular aneurysm repair (EVAR) in women, new radiation safety guidelines from the...

Silk Road Medical announces first patient enrolled in ROADSTER 3 post-approval...

Silk Road Medical has announced enrolment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicentre, single-arm...

Silk Road to evaluate TCAR in standard surgical risk patients with...

Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...
popular

Vascular News’ top 10 most popular stories of May 2022

Two-year data on the use of intravascular lithotripsy (IVL) in calcified peripheral disease treatment, an advertorial sponsored by Bentley exploring the role of bridging...

Silk Road Medical announces expanded Medicare coverage for TCAR in standard...

Silk Road Medical recently announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety...

Silk Road Medical announces FDA approval of expanded indications for the...

Silk Road Medical recently announced that the US Food and Drug Administration (FDA) approved expanded indications for the company's Enroute stent to include patients...
popular

Vascular News’ top 10 most popular stories of January 2022

Breakthrough designation for a new drug-eluting stent from Cook Medical, a meta-analysis on the safety of expedited carotid artery surgery vs. expedited stenting after...
tcar restenotic carotid lesions

Cost-effectiveness of TCAR versus carotid endarterectomy addressed in new study

A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularisation (TCAR; Silk Road Medical) were higher than those for...
tcar restenotic carotid lesions

TCAR may be associated with favourable outcomes for treatment of restenotic...

Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

First ever analysis of TCAR in standard surgical risk patients demonstrates...

Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...

Study finds hospital availability of TCAR associated with an improvement in...

Positive results from a comparative-effectiveness study involving transcarotid artery revascularisation (TCAR) have been published in JAMA Network Open, Silk Road Medical have announced. The study...

Favorable outcomes with TCAR versus carotid endarterectomy in patients with carotid...

Silk Road Medical announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the...

Silk Road Medical appoints Tammy Leitsinger to serve as vice president,...

Silk Road Medical has announced the appointment of Tammy Leitsinger to the position of vice president, Medical Affairs and Professional Education. In this new role, Leitsinger...

Silk Road Medical announces US$47 million financing

Silk Road Medical has received US$47 million in new funding led by new investors Norwest Venture Partners and funds managed by Janus Capital Management...

Comparable results found for transcarotid artery revascularisation and CEA at VEITH...

Silk Road Medical data presented at the VEITH Symposium have found comparable results for transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA), among other...